Dovonex
NDC 54868-6057
Product Information
Dovonex is a NDA-approved product labeled by Physicians Total Care, Inc.. This medication is used to treat psoriasis. It is supplied as a product. This product entry covers the primary NDC 54868-6057 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 54868-6057?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CALCIPOTRIENE (UNII: 143NQ3779B)
- CALCIPOTRIENE (UNII: 143NQ3779B) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)
- DIISOPROPANOLAMINE (UNII: 0W44HYL8T5)
- MENTHOL (UNII: L7T10EIP3A)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SODIUM CITRATE (UNII: 1Q73Q2JULR)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 212443 - Dovonex 0.005 % Topical Solution
- RxCUI: 212443 - calcipotriene 0.05 MG/ML Topical Solution [Dovonex]
- RxCUI: 212443 - Dovonex (as calcipotriene monohydrate) 0.005 % Topical Solution
- RxCUI: 212443 - Dovonex 0.005 % Scalp Solution
- RxCUI: 212443 - Dovonex 0.05 MG/ML Topical Solution
* Please review the full disclaimer at the bottom of this page.